#108: Dispensary by IYHP (24/03)
Dispensing the major healthcare updates of the entire week under 3 minutes along with some interesting reads and much more. Read on ⏩
💰 Major investments this week
Sakra World Hospital lines up ₹2,000 crore for Bengaluru expansion
Healthcare startup Qurex secures over $250K in Pre-Seed Funding Round
Lonza strikes $1.2B deal to buy mammoth Roche plant amid CDMO industry upheaval
Riding GLP-1 wave, Novo Nordisk lays out $560M to boost drug production in China
Healthcare industry chatbot firm Hippocratic AI raises $53M at $500M valuation
Lisbon-based UpHill secures €7 million Series A to scale its healthcare autopilot for doctors and nurses
The CareVoice raises $10M Series B, bucking the funding slowdown in health tech
🕮 What we are reading this week
How AI supports early disease detection in India
After years of ransomware attacks, health-care defenses still fail
Can 25,000 Cr Narayana turbocharge India’s low cost health innovation?
Avi Yaron: The Young Engineer, His Inoperable Brain Tumor and His Gift to Medicine
Collaborating for a Robust Medical Device Reimbursement Pathway in India
🇮🇳 National
👨⚕️ 2K doctors from India to plug UK's national health service shortage
🩺 MeraDoc, MakeMyTrip partner to offer real-time medical services across India
🤝 India pushes for health sector coop with Central Asia in SCO meet
📉 India surpasses WHO guidelines with 1:900 doc-to-population ratio: Kalita
🌎Global
🤝 Nvidia inks tie-ups with Abridge, GE HealthCare, and Microsoft as it expands its footprint in healthcare AI
Mayo launches new “Primary Care On-Demand” app
🖱️ Google's healthcare AI ambitions: New model for personal health coaching and Next Steps for gen AI
🏭 BMS-backed radio pharma specialist Ratio expands manufacturing deal with CDMO PharmaLogic
⚠️ Haiti healthcare system on the verge of collapse as gang warfare rages on
Did we miss anything? Perhaps you'd like to share your insights on Dispensary by crafting a guest post? Please shoot us a note at dispensary@iyhp.org or connect with us on LinkedIn.
That’s it, until next week.